240 related articles for article (PubMed ID: 33132244)
1. PD-1/PD-L1 affects Graves progression through lymphocytes on the proliferation, apoptosis and inflammatory cytokine secretion of thyroid follicular epithelial cells.
Han H; Fu X; Huang J; Zhang X; Yu J
J Toxicol Sci; 2020; 45(11):701-711. PubMed ID: 33132244
[TBL] [Abstract][Full Text] [Related]
2. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
Bossowski A; Urban M; Stasiak-Barmuta A
J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
[TBL] [Abstract][Full Text] [Related]
3. The Frequency of Intrathyroidal Follicular Helper T Cells Varies with the Progression of Graves' Disease and Hashimoto's Thyroiditis.
Cai Y; Wang Z; Liu X; Wei L; Li S; Zheng X; Yang T; Xu X
J Immunol Res; 2022; 2022():4075522. PubMed ID: 35224111
[TBL] [Abstract][Full Text] [Related]
4. Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
Wang F; Chen L; Shen Q; Liu T; Jiang L; Gu X; Chen L; Sun J; Liu C
Immunol Lett; 2015 May; 165(1):47-51. PubMed ID: 25839128
[TBL] [Abstract][Full Text] [Related]
5. High Levels of Thyroid Hormone Impair Regulatory T Cell Function Via Reduced PD-1 Expression.
Zhong Y; Lu TT; Liu XM; Liu BL; Hu Y; Liu S; Wang J; Li GQ; Mao XM
J Clin Endocrinol Metab; 2021 Aug; 106(9):2738-2753. PubMed ID: 33758937
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity.
Álvarez-Sierra D; Marín-Sánchez A; Ruiz-Blázquez P; de Jesús Gil C; Iglesias-Felip C; González Ó; Casteras A; Costa RF; Nuciforo P; Colobran R; Pujol-Borrell R
J Autoimmun; 2019 Sep; 103():102285. PubMed ID: 31182340
[TBL] [Abstract][Full Text] [Related]
7. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL
Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
[TBL] [Abstract][Full Text] [Related]
9. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model.
Saitoh O; Abiru N; Nakahara M; Nagayama Y
Endocrinology; 2007 Dec; 148(12):6040-6. PubMed ID: 17823258
[TBL] [Abstract][Full Text] [Related]
10. B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease.
Battifora M; Pesce G; Paolieri F; Fiorino N; Giordano C; Riccio AM; Torre G; Olive D; Bagnasco M
J Clin Endocrinol Metab; 1998 Nov; 83(11):4130-9. PubMed ID: 9814503
[TBL] [Abstract][Full Text] [Related]
11. Reactive glia promote development of CD103
Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
[TBL] [Abstract][Full Text] [Related]
12. CXCR6 within T-helper (Th) and T-cytotoxic (Tc) type 1 lymphocytes in Graves' disease (GD).
Aust G; Kamprad M; Lamesch P; Schmücking E
Eur J Endocrinol; 2005 Apr; 152(4):635-43. PubMed ID: 15817921
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells.
Li Y; Wang Z; Yu T; Chen B; Zhang J; Huang K; Huang Z
PLoS One; 2014; 9(9):e107183. PubMed ID: 25226272
[TBL] [Abstract][Full Text] [Related]
14. Human renal tubular epithelial cells suppress alloreactive T cell proliferation.
Demmers MW; Korevaar SS; Roemeling-van Rhijn M; van den Bosch TP; Hoogduijn MJ; Betjes MG; Weimar W; Baan CC; Rowshani AT
Clin Exp Immunol; 2015 Mar; 179(3):509-19. PubMed ID: 25310899
[TBL] [Abstract][Full Text] [Related]
15. Elevated follicular helper T cells and expression of IL-21 in thyroid tissues are involved in the pathogenesis of Graves' disease.
Zhang J; Ren M; Zeng H; Guo Y; Zhuang Z; Feng Z; Yan H; Xu M; Liang W; Yang C; Cheng H; Ding H; Yan L
Immunol Res; 2015 Jun; 62(2):163-74. PubMed ID: 25894310
[TBL] [Abstract][Full Text] [Related]
16. A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease.
Xu B; Wu D; Ying H; Zhang Y
Turk J Med Sci; 2019 Jun; 49(3):715-722. PubMed ID: 31023005
[TBL] [Abstract][Full Text] [Related]
17. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy.
Iijima T; Jojima T; Hosonuma S; Ohhira E; Tomaru T; Kogai T; Usui I; Aso Y
Endocr J; 2021 Oct; 68(10):1187-1195. PubMed ID: 33980771
[TBL] [Abstract][Full Text] [Related]
19. Frequencies of PD-1- positive T CD3+CD4+, T CD3+CD8+ and B CD19+ lymphocytes in female patients with Graves' disease and healthy controls- preliminary study.
Pyzik A; Grywalska E; Matyjaszek-Matuszek B; Smoleń A; Pyzik D; Roliński J
Mol Cell Endocrinol; 2017 Jun; 448():28-33. PubMed ID: 28284988
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
Saitoh O; Nagayama Y
Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
